Статті в журналах з теми "Dox-Induced Cardiotoxicity"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Dox-Induced Cardiotoxicity".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Sumneang, Natticha, Pongpan Tanajak, and Thura Tun Oo. "Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity." Molecules 28, no. 11 (May 24, 2023): 4294. http://dx.doi.org/10.3390/molecules28114294.
Ammar, El-Sayed M., Shehta A. Said, Ghada M. Suddek, and Sally L. El-Damarawy. "Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats." Canadian Journal of Physiology and Pharmacology 89, no. 4 (April 2011): 269–76. http://dx.doi.org/10.1139/y11-020.
Hamaamin, Karmand Salih, and Tavga Ahmed Aziz. "Doxorubicin-Induced Cardiotoxicity: Mechanisms and Management." Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 3 (December 10, 2022): 87–97. http://dx.doi.org/10.54133/ajms.v3i.90.
Zheng, Dong, Yi Zhang, Ming Zheng, Ting Cao, Grace Wang, Lulu Zhang, Rui Ni, et al. "Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity." Clinical Science 133, no. 13 (July 2019): 1505–21. http://dx.doi.org/10.1042/cs20181022.
Zhang, Wei, Zhixing Fan, Fengyuan Wang, Lin Yin, Jinchun Wu, Dengke Li, Siwei Song, Xi Wang, Yanhong Tang, and Congxin Huang. "Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3." Oxidative Medicine and Cellular Longevity 2023 (January 14, 2023): 1–23. http://dx.doi.org/10.1155/2023/9966355.
Mao, Jin Ning, Ai Jun Li, Liang Ping Zhao, Lan Gao, Wei Ting Xu, Xiao Su Hong, Wen Ping Jiang, and Jian Chang Chen. "PEG-PLGA Nanoparticles Entrapping Doxorubicin Reduced Doxorubicin-Induced Cardiotoxicity in Rats." Advanced Materials Research 912-914 (April 2014): 263–68. http://dx.doi.org/10.4028/www.scientific.net/amr.912-914.263.
Maneechote, Chayodom, Siriporn C. Chattipakorn, and Nipon Chattipakorn. "Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity." Pharmaceutics 15, no. 4 (April 7, 2023): 1182. http://dx.doi.org/10.3390/pharmaceutics15041182.
Kitakata, Hiroki, Jin Endo, Hidehiko Ikura, Hidenori Moriyama, Kohsuke Shirakawa, Yoshinori Katsumata, and Motoaki Sano. "Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis." International Journal of Molecular Sciences 23, no. 3 (January 26, 2022): 1414. http://dx.doi.org/10.3390/ijms23031414.
da Cunha Menezes Souza, Leonardo, Meng Chen, Yuji Ikeno, Daisy Maria Fávero Salvadori, and Yidong Bai. "The implications of mitochondria in doxorubicin treatment of cancer in the context of traditional and modern medicine." Traditional Medicine and Modern Medicine 03, no. 04 (December 2020): 239–54. http://dx.doi.org/10.1142/s2575900020300076.
Jiang, Lai, Yanping Gong, Yida Hu, Yangyang You, Jiawu Wang, Zhetao Zhang, Zeyuan Wei, and Chaoliang Tang. "Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis." Oxidative Medicine and Cellular Longevity 2020 (July 29, 2020): 1–11. http://dx.doi.org/10.1155/2020/2405135.
Cheng, Xiaoli, Dan Liu, Ruinan Xing, Haixu Song, Xiaoxiang Tian, Chenghui Yan, and Yaling Han. "Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling." BioMed Research International 2020 (October 19, 2020): 1–13. http://dx.doi.org/10.1155/2020/5923572.
Miranda, Carlos J., Hortence Makui, Ricardo J. Soares, Marc Bilodeau, Jeannie Mui, Hajatollah Vali, Richard Bertrand, Nancy C. Andrews, and Manuela M. Santos. "Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin." Blood 102, no. 7 (October 1, 2003): 2574–80. http://dx.doi.org/10.1182/blood-2003-03-0869.
Jiao, Yuheng, Yanyan Li, Jiayan Zhang, Song Zhang, Yafang Zha, and Jian Wang. "RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway." Biomolecules 12, no. 2 (February 12, 2022): 299. http://dx.doi.org/10.3390/biom12020299.
Hu, Xiaoping, Huagang Liu, Zhiwei Wang, Zhipeng Hu, and Luocheng Li. "miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice." Oxidative Medicine and Cellular Longevity 2019 (November 3, 2019): 1–13. http://dx.doi.org/10.1155/2019/1512326.
Bhagat, Anchit, and Eugenie S. Kleinerman. "Neutrophils contribute to Doxorubicin-Induced Cardiotoxicity." Journal of Immunology 206, no. 1_Supplement (May 1, 2021): 111.23. http://dx.doi.org/10.4049/jimmunol.206.supp.111.23.
Yu, Yangsheng, Degang Guo, and Lin Zhao. "MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b." Evidence-Based Complementary and Alternative Medicine 2022 (July 15, 2022): 1–13. http://dx.doi.org/10.1155/2022/4364779.
Mao, Meijiao, Wang Zheng, Bin Deng, Youhua Wang, Duan Zhou, Lin Shen, Wankang Niku, and Na Zhang. "Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes." PLOS ONE 18, no. 10 (October 12, 2023): e0292124. http://dx.doi.org/10.1371/journal.pone.0292124.
Zhao, Yintao, Jingjing Sun, Wei Zhang, Meng Peng, Jun Chen, Lu Zheng, Xiangqin Zhang, Haibo Yang, and Yuan Liu. "Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2." Oxidative Medicine and Cellular Longevity 2020 (August 3, 2020): 1–11. http://dx.doi.org/10.1155/2020/3598715.
Wang, Tao, Chuqiao Yuan, Jia Liu, Liangyan Deng, Wei Li, Junling He, Honglin Liu, Liping Qu, Jianming Wu, and Wenjun Zou. "Targeting Energy Protection as a Novel Strategy to Disclose Di’ao Xinxuekang against the Cardiotoxicity Caused by Doxorubicin." International Journal of Molecular Sciences 24, no. 2 (January 4, 2023): 897. http://dx.doi.org/10.3390/ijms24020897.
Wang, Jingya, Lin Yao, Xiaoli Wu, Qi Guo, Shengxuan Sun, Jie Li, Guoqi Shi, Ruth B. Caldwell, R. William Caldwell, and Yongjun Chen. "Protection against Doxorubicin-Induced Cardiotoxicity through Modulating iNOS/ARG 2 Balance by Electroacupuncture at PC6." Oxidative Medicine and Cellular Longevity 2021 (March 20, 2021): 1–17. http://dx.doi.org/10.1155/2021/6628957.
Lue, Yanhe, Chen Gao, Ronald Swerdloff, James Hoang, Rozeta Avetisyan, Yue Jia, Meng Rao, et al. "Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity." American Journal of Physiology-Heart and Circulatory Physiology 315, no. 3 (September 1, 2018): H634—H643. http://dx.doi.org/10.1152/ajpheart.00155.2018.
Li, Jing, Huiping Liu, Srinivasan Ramachandran, Gregory B. Waypa, Jun-Jie Yin, Chang-Qing Li, Mei Han, et al. "Grape Seed Proanthocyanidins Ameliorate Doxorubicin-Induced Cardiotoxicity." American Journal of Chinese Medicine 38, no. 03 (January 2010): 569–84. http://dx.doi.org/10.1142/s0192415x10008068.
Smuder, Ashley J., Andreas N. Kavazis, Kisuk Min, and Scott K. Powers. "Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals." Journal of Applied Physiology 115, no. 2 (July 15, 2013): 176–85. http://dx.doi.org/10.1152/japplphysiol.00924.2012.
Ashour, Abdelkader E., Mohamed M. Sayed-Ahmed, Adel R. Abd-Allah, Hesham M. Korashy, Zaid H. Maayah, Hisham Alkhalidi, Mohammed Mubarak, and Abdulqader Alhaider. "Metformin Rescues the Myocardium from Doxorubicin-Induced Energy Starvation and Mitochondrial Damage in Rats." Oxidative Medicine and Cellular Longevity 2012 (2012): 1–13. http://dx.doi.org/10.1155/2012/434195.
Li, Ling-Li, Li Wei, Ning Zhang, Wen-Ying Wei, Can Hu, Wei Deng, and Qi-Zhu Tang. "Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway." BioMed Research International 2020 (June 8, 2020): 1–11. http://dx.doi.org/10.1155/2020/8593617.
Li, Siying, Wenjuan Wang, Ting Niu, Hui Wang, Bin Li, Lei Shao, Yimu Lai, et al. "Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction." Oxidative Medicine and Cellular Longevity 2014 (2014): 1–15. http://dx.doi.org/10.1155/2014/748524.
Haesen, Sibren, Manon Marie Jager, Aline Brillouet, Iris de Laat, Lotte Vastmans, Eline Verghote, Anouk Delaet, et al. "Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity." Antioxidants 13, no. 1 (January 17, 2024): 112. http://dx.doi.org/10.3390/antiox13010112.
Shan, Lingling, Yulong Huo, Siyu Li, Wanrong Li, Jing Wang, Yang Yang, Langzi Wang, and Lin Chen. "Geraniin-Based Self-Assemble Nanoplatform for Antioxidation Reduced Cardiotoxicity and Tumor Synergistic Therapy." Journal of Biomedical Nanotechnology 19, no. 5 (May 1, 2023): 758–69. http://dx.doi.org/10.1166/jbn.2023.3580.
Ono, Masaya, Yoichi Sunagawa, Saho Mochizuki, Takahiro Katagiri, Hidemichi Takai, Sonoka Iwashimizu, Kyoko Inai, et al. "Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis." Cancers 14, no. 3 (January 28, 2022): 683. http://dx.doi.org/10.3390/cancers14030683.
Jiang, Yu, Yanjuan Liu, Wen Xiao, Dandan Zhang, Xiehong Liu, Huiqiong Xiao, Sanli You, and Lili Yuan. "Xinmailong Attenuates Doxorubicin-Induced Lysosomal Dysfunction and Oxidative Stress in H9c2 Cells via HO-1." Oxidative Medicine and Cellular Longevity 2021 (March 27, 2021): 1–11. http://dx.doi.org/10.1155/2021/5896931.
Taylor, Justin R., and Kyra Harames. "Abstract 4771: Prevention of doxorubicin-induced cardiotoxicity by benfotiamine." Cancer Research 83, no. 7_Supplement (April 4, 2023): 4771. http://dx.doi.org/10.1158/1538-7445.am2023-4771.
Koczurkiewicz-Adamczyk, Paulina, Katarzyna Klaś, Agnieszka Gunia-Krzyżak, Kamil Piska, Kalina Andrysiak, Jacek Stępniewski, Sławomir Lasota, et al. "Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin." International Journal of Molecular Sciences 22, no. 12 (June 9, 2021): 6217. http://dx.doi.org/10.3390/ijms22126217.
Liu, Yuzhou, Liying Zhou, Binbin Du, Yuan Liu, Junhui Xing, Sen Guo, Ling Li, and Hongrui Chen. "Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway." Oxidative Medicine and Cellular Longevity 2021 (August 6, 2021): 1–18. http://dx.doi.org/10.1155/2021/9984330.
Lee, Eun Ji, Woong Bi Jang, Jaewoo Choi, Hye Ji Lim, Sangmi Park, Vinoth Kumar Rethineswaran, Jong Seong Ha, et al. "The Protective Role of Glutathione against Doxorubicin-Induced Cardiotoxicity in Human Cardiac Progenitor Cells." International Journal of Molecular Sciences 24, no. 15 (July 28, 2023): 12070. http://dx.doi.org/10.3390/ijms241512070.
Egwuatu, Ifeanyi Anthony, Chiadikobi Lawrence Ozoemena, Emeka Williams Ugwuishi, Christian Chiemeka Ozor, Augustine Oviosun, and Favour Onwene. "Deciphering the Ameliorative Potential of 5, 7-dihydroxyflavone (Chrysin) on Doxorubicin-Induced Cardiotoxicity by Modulating Oxidative Stress in Rats." Scholars International Journal of Anatomy and Physiology 6, no. 11 (November 23, 2023): 181–90. http://dx.doi.org/10.36348/sijap.2023.v06i11.005.
Abdul Karim, Lubna Zuhair, Inam Sameh Arif, and Fouad A. Al Saady. "Lipidomics application to explain acute cardiotoxicity induced by doxorubicin." Al Mustansiriyah Journal of Pharmaceutical Sciences 19, no. 4 (December 1, 2019): 161–69. http://dx.doi.org/10.32947/ajps.v19i4.647.
Chen, Sida, Yang Huang, Suiqing Huang, Zhuoming Zhou, Kaizheng Liu, Jinyu Pan, and Zhongkai Wu. "M2b macrophages protect against doxorubicin induced cardiotoxicity via alternating autophagy in cardiomyocytes." PLOS ONE 18, no. 7 (July 27, 2023): e0288422. http://dx.doi.org/10.1371/journal.pone.0288422.
Hamada, Juri, Altansarnai Baasanjav, Natsumi Ono, Kazuya Murata, Koichiro Kako, Junji Ishida, and Akiyoshi Fukamizu. "Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity." American Journal of Physiology-Heart and Circulatory Physiology 308, no. 8 (April 15, 2015): H931—H941. http://dx.doi.org/10.1152/ajpheart.00703.2013.
Wang, Yuewen, Xu Chao, Fiaz ud Din Ahmad, Hailong Shi, Hania Mehboob, and Waseem Hassan. "Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity." Cardiology Research and Practice 2019 (December 23, 2019): 1–8. http://dx.doi.org/10.1155/2019/7395239.
Li, Jun, Weiguo Wan, Tao Chen, Suiyang Tong, Xuejun Jiang, and Wanli Liu. "miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice." BioMed Research International 2019 (July 4, 2019): 1–11. http://dx.doi.org/10.1155/2019/1528278.
Gyongyosi, Alexandra, Nikolett Csaki, Agota Peto, Kitti Szoke, Ferenc Fenyvesi, Ildiko Bacskay, and Istvan Lekli. "BGP-15 Protects against Doxorubicin-Induced Cell Toxicity via Enhanced Mitochondrial Function." International Journal of Molecular Sciences 24, no. 6 (March 9, 2023): 5269. http://dx.doi.org/10.3390/ijms24065269.
Al-Shabanah, Othman A., Abdulaziz M. Aleisa, Mohamed M. Hafez, Salim S. Al-Rejaie, Abdulaziz A. Al-Yahya, Saleh A. Bakheet, Mohamed M. Al-Harbi та Mohamed M. Sayed-Ahmed. "Desferrioxamine Attenuates Doxorubicin-Induced Acute Cardiotoxicity through TFG-β/Smad p53 Pathway in Rat Model". Oxidative Medicine and Cellular Longevity 2012 (2012): 1–7. http://dx.doi.org/10.1155/2012/619185.
Räsänen, Markus, Joni Degerman, Tuuli A. Nissinen, Ilkka Miinalainen, Risto Kerkelä, Antti Siltanen, Janne T. Backman, et al. "VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection." Proceedings of the National Academy of Sciences 113, no. 46 (October 31, 2016): 13144–49. http://dx.doi.org/10.1073/pnas.1616168113.
Haesen, Sibren, Eline Verghote, Ellen Heeren, Esther Wolfs, Dorien Deluyker, and Virginie Bito. "Pyridoxamine Attenuates Doxorubicin-Induced Cardiomyopathy without Affecting Its Antitumor Effect on Rat Mammary Tumor Cells." Cells 13, no. 2 (January 9, 2024): 120. http://dx.doi.org/10.3390/cells13020120.
Law, David, Mitchel A. Magrini, Jacob A. Siedlik, Joan Eckerson, Kristen M. Drescher, and Eric C. Bredahl. "Creatine and Resistance Training: A Combined Approach to Attenuate Doxorubicin-Induced Cardiotoxicity." Nutrients 15, no. 18 (September 19, 2023): 4048. http://dx.doi.org/10.3390/nu15184048.
Legi, Ashiq, Emma Rodriguez, Thomas K. Eckols, Cyrus Mistry, and Prema Robinson. "Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity." Cancers 13, no. 7 (April 6, 2021): 1732. http://dx.doi.org/10.3390/cancers13071732.
Tao, Rong-Hua, Masato Kobayashi, Yuanzheng Yang, and Eugenie S. Kleinerman. "Exercise Inhibits Doxorubicin-Induced Damage to Cardiac Vessels and Activation of Hippo/YAP-Mediated Apoptosis." Cancers 13, no. 11 (June 1, 2021): 2740. http://dx.doi.org/10.3390/cancers13112740.
Zhang, Wen-Bin, Xin Lai, and Xu-Feng Guo. "Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis." Oxidative Medicine and Cellular Longevity 2021 (January 26, 2021): 1–14. http://dx.doi.org/10.1155/2021/8860883.
Rong, Jing, Lizhong Li, Li Jing, Haiqin Fang, and Shuangqing Peng. "JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes." International Journal of Toxicology 35, no. 3 (November 2, 2015): 317–26. http://dx.doi.org/10.1177/1091581815614261.
Ashour, Osama M., Ashraf B. Abdel-Naim, Hossam M. Abdallah, Ayman A. Nagy, Ahmed M. Mohamadin, and Essam A. Abdel-Sattar. "Evaluation of the Potential Cardioprotective Activity of Some Saudi Plants against Doxorubicin Toxicity." Zeitschrift für Naturforschung C 67, no. 5-6 (June 1, 2012): 297–307. http://dx.doi.org/10.1515/znc-2012-5-609.